Come up with a name for your new list and we'll add to it:
TetraGenetics raised a round of funding on January 14, 2016. Investors include
National Institute of General Medical Sciences.
Tetragenetics is an early-stage biotechnology company meeting the needs of customers who seek a cost-effective alternative platform technology for the production of genetically engineered proteins. Th…